These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 37476550)

  • 1. Retracted: A Prognostic Model for Brain Glioma Patients Based on 9 Signature Glycolytic Genes.
    International BR
    Biomed Res Int; 2024; 2024():9854370. PubMed ID: 38550201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retracted: Considering Computational Mathematics IGHG3 as Malignant Melanoma Is Associated with Immune Infiltration of Malignant Melanoma.
    International BR
    Biomed Res Int; 2024; 2024():9829716. PubMed ID: 38550022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: Current Status of Malignant Tumors after Organ Transplantation.
    International BR
    Biomed Res Int; 2024; 2024():9879310. PubMed ID: 38550130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Osmotic Demyelination Syndrome: Clinical, Neuroimaging Characteristics, and Outcomes in a Series of 18 Cases.
    International BR
    Biomed Res Int; 2024; 2024():9847541. PubMed ID: 38550040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: SFRP2 is a Novel Diagnostic Biomarker and Suppresses the Proliferation of Pituitary Adenoma.
    Journal Of Oncology
    J Oncol; 2023; 2023():9813986. PubMed ID: 37476559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Hyperfractionation versus Conventional Fractionation of Preoperative Intensity-Modulated Radiotherapy with Oral Capecitabine in Locally Advanced Mid-Low Rectal Cancer: A Propensity Score Matching Study.
    Oncology JO
    J Oncol; 2023; 2023():9892163. PubMed ID: 37476561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Factors Affecting Willingness on Sharing of Electronic Health Records Data: A Survey on Chinese Residents.
    Oncology JO
    J Oncol; 2023; 2023():9760135. PubMed ID: 37476560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: The Effect of High-Quality Nursing Management on Thyroid Tumor Patients after Bipolar Coagulation.
    Oncology JO
    J Oncol; 2023; 2023():9842579. PubMed ID: 37476558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: The Application of Whole-Process Case Management in Patients with Triple-Negative Breast Cancer.
    Oncology JO
    J Oncol; 2023; 2023():9816256. PubMed ID: 37476557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: Screening of Key Prognosis Genes of Lung Adenocarcinoma Based on Expression Analysis on TCGA Database.
    Oncology JO
    J Oncol; 2023; 2023():9815674. PubMed ID: 37476556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Deep Learning-Based Health Management Model Application in Extreme Myopia Eye Vision Monitoring and Risk Prediction.
    Oncology JO
    J Oncol; 2023; 2023():9850715. PubMed ID: 37476555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Staged Nursing Intervention: The Effect of the Compliance in Liver Cancer Patients with Interventional Therapy.
    Journal Of Oncology
    J Oncol; 2023; 2023():9874617. PubMed ID: 37476554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Clinical Efficacy of Single-Port Thoracoscopic Lobectomy versus Three-Port Thoracoscopic Lobectomy for Lung Cancer.
    Oncology JO
    J Oncol; 2023; 2023():9837027. PubMed ID: 37476553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: PRR15 Is a Novel Diagnostic and Prognostic Biomarker in Papillary Thyroid Cancer and Modulates the Tumor Microenvironment.
    Oncology JO
    J Oncol; 2023; 2023():9839681. PubMed ID: 37476552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: Red Blood Cell Membrane-Camouflaged Gold Nanoparticles for Treatment of Melanoma.
    Oncology JO
    J Oncol; 2023; 2023():9835164. PubMed ID: 37476551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Analysis of Clinical Characteristics and Risk Factors of Postoperative Recurrence and Malignant Transformation of Low-Grade Glioma.
    Oncology JO
    J Oncol; 2023; 2023():9832716. PubMed ID: 37476550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Peritumor Edema Serves as an Independent Predictive Factor of Recurrence Patterns and Recurrence-Free Survival for High-Grade Glioma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9761763. PubMed ID: 37503375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Correlations between Clinical Characteristics and Prognosis in Patients with Grade II Glioma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9765049. PubMed ID: 37387973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Clinical Characteristics and Risk Factors of Postoperative Recurrence and Malignant Transformation of Low-Grade Glioma.
    Luo C; Luo Q; Xu Y; Song J; Liu Y; Wang L; Dong Z; Huang W; Yu H; Li J
    J Oncol; 2022; 2022():4948943. PubMed ID: 36090892
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.